Revvity is a global provider of health science solutions and technologies that serve the complete workflow from drug discovery and development through diagnosis and treatment. The company operates two main segments: Life Sciences, which supplies reagents, instruments, software, and licensing technologies to pharmaceutical, biotech, and research institutions for disease understanding and treatment development; and Diagnostics, which provides reproductive health, immunodiagnostics, and emerging market diagnostic products to hospitals, medical laboratories, and clinicians. The company generates revenue from the sale of instruments and analyzer systems, reagents and assay kits, software licenses, technology licensing services, and laboratory testing services, supported by a global sales and service organization that reaches customers across multiple countries.